Bangkok Dusit Medical Services Public Company Limited (SET: BDMS) has announced its 1Q25 consolidated financial statement through the Stock Exchange of Thailand as follows;
Quarter | 1Q25 | 1Q24 |
Net Profit (Loss) Million Baht |
4,346.44 | 4,073.50 |
Earning Per Share (Baht) |
0.2700 | 0.2600 |
% Change | 6.70 |
BDMS and its subsidiaries reported net profit for the first quarter of 2025 of THB 4.346 billion, an increase of 7% YoY, due to good revenue growth of Thai and international patients together with continued cost control and tax privileges from various investment promotion measures.
As for its operating income, the company reported a total of THB 28.453 billion, an increase of 6% from 1Q24. The growth was mainly attributable to the following factors:
- Revenues from hospital operations were THB 27.078 billion, an increase of THB 1.552 billion or 6% YoY, driven by Thai patient revenues growth of 4% YoY and international patient revenues growth of 11% YoY.
- The international revenue growth was primarily attributed to growth of patients from Qatar 56%, UK 24% and USA 22% YoY.
- The revenue proportion between Thai and international patients slightly changed from 70%:30% in 1Q24 to 69%:31% in 1Q25.
- Revenues from sales of goods were THB 1.006 billion, decreased by 7% YoY due mainly to a decrease in sales of Medicpharma Co., Ltd.
- Other incomes were THB 369 million, increased by 15% YoY mainly from higher revenue of Mövenpick BDMS Wellness Resort.
When compared to the previous quarter, the total operating income increased by 2%. Thai patient revenues increased by 1% while international patient revenues increased 8%.
BDMS also reported total operating expenses & depreciation of THB 22.839 billion, an increase of THB 1.21 billion or 6% YoY.
- The rise in total operating expenses & depreciation was mainly from higher doctor fees, drug and medical supply expenses, in line with revenue growth, as well as an increase in depreciation and amortization expenses resulting from the expansion of network hospitals.
The consolidated expenses & depreciation increased by 1% QoQ, growing slightly slower than revenues.